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Interspecies antigenic determinants have been used as markers to study the evolution of oncoviruses. By radioimmunologic techniques, it has been possible to detect crossreactivities among the major structural proteins of prototype viruses representing each of the three major Oncovirinae genera. Two different subsets of interspecies antigenic determinants were demonstrated. One encompasses known type B and type D viruses; the other is shared by type D and mammalian type C viruses. Such determinants were also demonstrated in certain as yet unclassified oncoviruses. These findings provide experimental evidence supporting the concept of an evolutionary relationship among the three major oncovirus genera.
Oncoviruses, a subfamily of the Retroviridae family (1) , are etiologically involved in naturally occurring tumors of a wide variety of vertebrate species. Moreover, these viruses can exhibit a unique mode of transmission within cellular DNA of their hosts as endogenous viruses (2) . Different oncovirus genera have been classified according to morphologic criteria (3) . Type B viruses have so far been found only in murine species, in which they have been established as etiologically responsible for mammary tumors (4) . Type C viruses, which are widely distributed among birds and mammals, have been shown to cause leukemias and sarcomas (2, 5) . The recently described type D oncoviruses are to date limited to primate species (6) (7) (8) ; the oncogenicity of these viruses has yet to be firmly established.
In recent years, one of the most useful approaches in establishing evolutionary linkage between viruses has involved demonstration of shared antigenic determinants in their translational products. Interspecies crossreactivity was initially shown for several early type C virus isolates (9, 10) . The advent of radioimmunologic techniques (11, 12) made it possible to demonstrate the presence of interspecies determinants common to the major structural protein (p3Os) of all known mammalian type C viruses (13) (14) (15) . Similar conclusions have been drawn from partial sequence analysis of diverse viral p30s (16) . Immunologic investigations have been extended to include other translational products representing more than two-thirds of the type C viral coding capacity (17, 18) . All of these studies have led to the conclusion that mammalian type C viruses arose from a common progenitor (19) . (26) , RD114 (27) , and baboon (Papio cynocephalus) endogenous virus (BEV) (28) . Avian type C viruses, including avian myeloblastosis virus (AMV) (29), Rous sarcoma virus (RSV) (30) , and the A strain of the reticuloendotheliosis virus group (31), were also analyzed. Type D oncoviruses included Mason-Pfizer monkey virus (MPMV) (6), langur endogenous virus (Po-1-Lu) (8) , and a squirrel monkey retrovirus (SMRV) (7) . As yet, unclassified oncoviruses, such as the endogenous viper retrovirus (VRV) (32), the guinea pig virus (GPV) (33) , and the infectious bovine leukemia virus (BoLV) (34) were also studied.
Antisera. Antisera were prepared by immunization of goats and rabbits with detergent-disrupted viruses purified by isopycnic banding in sucrose gradients. Animals were immunized for up to 8 months with periodic (biweekly) injections of immunogen (nS300 ,ug total protein). Serum Table 1 , according to methods previously described (48, 49) . Doubleantibody precipitation and competition radioimmunoassays for these viral proteins were perfomed as described (50, 51 The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C §1734 solely to indicate this fact. Antisera prepared against purified viruses were tested for observations concerning the antigenic crossreactivity of this their ability to precipitate the '25I-labeled major structural virus and primate type D viruses (44) . proteins of viruses representing the three major oncoviral genera Kinetics of Interspecies Antibody Production. The de- (Table 1 ). Several striking cross-reactivities were observed tection of the immunologic crossreactivities described above among oncoviruses previously thought to be unrelated (Table  was made possible by a careful analysis of the kinetics of anti-2). Antisera directed against MPMV and SMRV type D viruses body production. Fig. 1 shows the kinetics of appearance of were able to precipitate the major structural protein of MMTV, some of the immunologic reactivities observed in a represena prototype type B virus. Moreover, anti-SMRV serum recogtative rabbit antiserum elicited against SMRV. Whereas the nized antigenic determinants of the p30 protein of R-MuLV, antibodies capable of recognizing R-MuLV p30 were trana well-characterized infectious mouse type C virus.
siently detected, those interacting with MMTV p26 required Two other positive immunoprecipitations involved viruses more than 7 months of continuous immunization before they that have not been definitively classified as type B, C, or D were consistently observed. In contrast, the kinetics of antibody according to ultrastructural observations. VRV, which recently formation against the highly related MPMV p26 protein were has been found to be immunologically related to endogenous similar to those observed against the homologous SMRV p35 primate type D viruses (45) , showed antigenic homology with protein.
In both cases, the high-titered antibodies found after <20  <20  <20  <20  <20  <20  <20  RSV  <20  <20  <20 180,000  <20  <20  <20  <20  <20  <20  MMTV  <20  <20  <20  <20  <20  <20 60,000  <20  <20  <20  SMRV  80  <20  <20  <20  1,200 120,000  160  <20  140  <20  GPV  <20  <20  <20  <20  <20  <20  160  <20  80,000  <20  VRV  <20  80  <20  <20  2,500  <20  <20 320,000  160  <20  BoLV  <20  <20  <20  <20  <20  <20  <20  <20  <20  80,000  Goat antisera elicited against:  R-MuLV  250,000  2,500  2,000  <20  <20  <20  <20  <20  <20  <20  SSAV  5,000 250,000  2,000  <20  <20  <20  <20  <20  <20  <20   RD114 endogenous feline virus   1,200  1,200 200,000  <20  <20  <20  <20  <20  <20  <20  AMV  <20  <20  <20 400,000  <20  <20  <20  <20  <20  <20  MMTV  <20  <20  <20  <20  <20  <20 80,000  <20  <20  <20  MPMV  <20  <20  <20  <20 600,000  5,000  80  320  240  <20  SMRV  <20  <20  <20  <20  2,500  80,000  <20  <20  200  <20  GVP  <20  <20  <20  <20  <20  <20  <20  <20 120,000  <20  VRV  <20  <20  <20  <20  <20  <20  <20 320,000  <20  <20  BoLV  <20  <20  <20  <20  <20  <20  <20  <20  <20 Immunologic crossreactivity was also detected between SMRV p35 and R-MuLV p3O, thus linking these prototype type D and type C oncoviruses. Whereas all known type D viruses appeared to possess this particular subset of conserved antigenic determinants, only certain type C viruses exhibited significant competition in the anti-SMRV antiserum/125I-labeled R-MuLV p30 assay. They included those of rodent (R-MuLV; BALB: virus-2), primate (SSAV, GaLV), carnivore (FeLV), and cervine (deer kidney virus) origin but not those endogenous to certain feline species (RD114) or to Old World primates (BEV). Finally, endogenous viper (VRV) and to a lesser extent guinea pig (GPV) viruses also competed in this assay. The fact that MMTV showed no detectable crossreactivity indicates that the major structural protein of type D viruses possesses at least two distinct subsets of antigenic determinants, crossreactive with the corresponding proteins of type B and type C oncoviruses, respectively. As such, these findings are evidence for evolutionary linkage among the three major genera of oncoviruses genera (Fig. 2) . Certain as yet unclassified endogenous retroviruses, including VRV and GPV, were also shown to exhibit broadly reactive antigenic determinants shared with the known oncovirus genera. Although RD114 and BEV, as well as the avian reticuloendotheliosis virus group, did not appear to possess these highly conserved determinants, the evidence strongly argues that these viruses have all evolved from the common progenitor of mammalian type C viruses (13-19, 53, 54) . Recently, Orozslan et al. (55) reported that the NH2-terminal amino acid sequence of BoLV p24 exhibits statistically significant analogies with the corresponding region of the major structural proteins of mammalian type C viruses. Thus, at the present time, only members of the avian sarcoma/leukosis group remain to be evolutionarily linked among the oncovirus subfamily of Retrovirinae.
The detection of highly conserved determinants of the major structural proteins of oncoviruses was made possible by systematic efforts to elicit appropriate antibodies and to improve the conditions for isolation of proteins utilized as radiolabeled probes. These approaches included use of clonal viruses propagated under conditions known to minimize the occurrence of defective particles and rapid harvesting for protein purification so as to minimize damage to virion components. The variable and sometimes transient patterns of expression of the broad interspecies antibodies to these highly conserved determinants, as well as the generally low titers exhibited, probably account for previous failure to detect such reactivities. Another observation in this and related studies (45, 54) has been the somewhat preferential humoral response of rabbits compared to goats against these interspecies determinants. Whether this is due to chance or is a consequence of differential expression or content of endogenous retroviruses is not known.
It has been postulated that antigenic crossreactivities among proteins may arise from convergent evolution of functional properties (56) . Our findings demonstrate that at least two different subsets of antigenic determinants were conserved among the major structural proteins of oncoviruses. If it is assumed that the major structural proteins of these viruses have a similar role, any common antigenic determinants due to convergent evolution might be expected to be present in all of the analogous proteins. Because this was not found to be the case, we consider convergent evolution to be an unlikely explanation for the shared antigenic determinants among oncoviral structural proteins. To date, there is not sufficient evidence to determine whether present oncoviruses have diverged from a common progenitor or have originated by recombination of ancestor viruses of independent evolutionary lineage. The recent demonstration that the respective translational products of known mammalian type C viruses share well-conserved antigenic determinants has made it possible to conclude that this major group has evolved from a common progenitor (19) . However, there is evidence that recombination has also played a role in oncovirus evolution (57) (58) (59) . Whichever mechanism has been the more important, our findings establish strong evidence for evolutionary relatedness among the three major oncovirus genera.
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